New England Journal of Medicine publishes CReATe team!

Some people are born with a “Balanced chromosomal rearrangement” (these are called translocations or inversions). When one partner has this, it may be associated with infertility, recurrent miscarriages, and, in some cases, an increased risk to the health of their children. The Reproductive Genetics team at the CReATe Fertility Centre, led by Drs. Madjunkova and Librach, just published a groundbreaking study in the New England Journal of Medicine (NEJM), the most prestigious journal in medicine. For the first time, they describe a new method, based on a cutting-edge technology called nanopore sequencing, to distinguish embryos having the balanced chromosome rearrangement vs those which don’t. Using this technology, parents can avoid passing this abnormality on to their children and future generations.

The New England Journal of Medicine is a world leading medical journal published continuously for over 200 years. It is the most widely read, cited and influential medical journal in the world with the highest impact factor.